Skip to main content
Cipher Street

Insider trades, decoded

Public Beta — All features are free while we're in beta. We'd love your feedback.

Organon & Co.(OGN)

Pharmaceuticals · SEC Form 4 Insider Trading Filings

Recent Insider Filings (143 total)

DateInsiderTypeSharesTrade PriceValueOwn ChgFlags
2026-05-06
Holzbaur Lynette
SVP and Corporate Controller
Sale26,448$13.35$353K>-99%
2026-05-06
Holzbaur Lynette
SVP and Corporate Controller
Purchase26,448$13.35$353K+100%
2026-03-31
Morrissey Joseph T. Jr.
Interim CEO
Exercise24,584+24%
2026-03-31
Holzbaur Lynette
SVP and Corporate Controller
Exercise10,967+63%
2026-03-31
Nisita Vittorio
Head of Global Business Svcs
Exercise13,000+21%
2026-03-31
Weaver Kirke
Gen. Counsel & Corp. Secy.
Exercise18,513+24%
2026-03-31
Falcione Aaron
Chief Human Resources Officer
Exercise17,925+21%
2026-03-31
Walsh Matthew M
Chief Financial Officer
Exercise33,593+18%
2026-03-31
Stahler Rachel A
Chief Information Officer
Exercise18,867+19%
2026-03-31
Karp Daniel
Executive VP, Corp. Dev.
Exercise18,053+34%
2026-03-31
Arjona Ferreira Juan Camilo
Head of R&D & CMO
Exercise13,431+63%
2026-03-31
Drinane Juliana Papa
Interim Head of Mfg & Supply
Exercise16,451+81%
2026-03-29
Morrissey Joseph T. Jr.
Interim CEO
Exercise9,752+10%
2026-03-29
Walsh Matthew M
Chief Financial Officer
Exercise15,071+8%
2026-03-29
Falcione Aaron
Chief Human Resources Officer
Exercise8,422+10%
2026-03-29
Arjona Ferreira Juan Camilo
Head of R&D & CMO
Exercise8,865+59%
2026-03-29
Drinane Juliana Papa
Interim Head of Mfg & Supply
Exercise7,979+46%
2026-03-29
Nisita Vittorio
Head of Global Business Svcs
Exercise5,762+10%
2026-03-29
Weaver Kirke
Gen. Counsel & Corp. Secy.
Exercise7,757+11%
2026-03-29
Karp Daniel
Executive VP, Corp. Dev.
Exercise14,184+30%
2026-03-29
Holzbaur Lynette
SVP and Corporate Controller
Exercise5,319+36%
2026-03-29
Stahler Rachel A
Chief Information Officer
Exercise8,200+8%
2025-11-13
Morrissey Joseph T. Jr.
Interim CEO
Grant131,233
2025-11-13
Drinane Juliana Papa
Interim Head of Mfg & Supply
Grant65,616
2025-11-12
Cox Carrie Smith
Executive Chair
Purchase65,400$7.67$502K+525%
Large
2025-11-07
Drinane Juliana Papa
Interim Head of Mfg & Supply
Exercise3,626+25%
2025-11-07
Holzbaur Lynette
SVP and Corporate Controller
Exercise2,417+19%
2025-11-07
Arjona Ferreira Juan Camilo
Head of R&D & CMO
Exercise6,446+26%
2025-11-05
Holzbaur Lynette
SVP and Corporate Controller
Exercise3,037+28%
2025-08-11
Arjona Ferreira Juan Camilo
Head of R&D & CMO
Exercise11,519+66%
2025-07-01
Sequeira Ramona
Director
Grant21,890
2025-06-13
Cox Carrie Smith
Executive Chair
Grant23,904
2025-06-13
Essner Robert
Director
Grant23,904
2025-06-13
Ezekowitz Alan
Director
Grant23,904
2025-06-13
Gayle Helene D
Director
Grant23,904
2025-06-13
Lazarus Rochelle B
Director
Grant23,904
2025-06-13
Whiteford Grace Puma
Director
Grant23,904
2025-06-13
Patton Cynthia M
Director
Grant23,904
2025-06-13
Sharp Shalini
Director
Grant23,904
2025-06-13
Leone Deborah R
Director
Grant23,904
2025-06-13
Ozuah Philip
Director
Grant23,904
2025-03-31
Ali Kevin
Chief Executive Officer
Exercise109,204+72%
2025-03-31
Morrissey Joseph T. Jr.
Interim CEO
Exercise21,483+41%
2025-03-31
Nisita Vittorio
Head of Global Business Svcs
Exercise13,231+42%
2025-03-31
DiMarco Kathryn
Corporate Controller
Exercise23,435+140%
2025-03-31
Weaver Kirke
Gen. Counsel & Corp. Secy.
Exercise21,376+88%
2025-03-31
Arjona Ferreira Juan Camilo
Head of R&D & CMO
Exercise8,865+76%
2025-03-31
Walsh Matthew M
Chief Financial Officer
Exercise34,870+34%
2025-03-31
Stahler Rachel A
Chief Information Officer
Exercise18,334+30%
2025-03-31
Karp Daniel
Executive VP, Corp. Dev.
Exercise34,677+352%

Data sourced from SEC EDGAR. This page is for informational purposes only and does not constitute financial advice.